Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma	Recruiting	Phase 2	2026-07-09		NCT07586124

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Lepu Biopharma Co., Ltd.	15

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer Hospital of Shantou University Medical College	Shantou	China	11
Guangxi Medical University Cancer Hospital	Nanning	China	24
Hubei Cancer Hospital	Wuhan	China	95
Hunan Cancer Hospital	Changsha	China	123
Liaoning Cancer Hospital & Institute	Shenyang	China	16
Ningbo Medical Center Lihuili Hospital	Ningbo	China	3
Peking University Cancer Hospital	Beijing	China	32
Shanghai East Hospital	Shanghai	China	38
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine	Shanghai	China	3
Sun Yat-sen Memorial Hospital, Sun Yat-sen University	Guangzhou	China	67
Sun Yat-sen University Cancer Center	Guangzhou	China	315
The First Affiliated Hospital of Fujian Medical University	Fuzhou	China	53
The Fourth Hospital of Hebei Medical University	Shijiazhuang	China	30
Xiangya Hospital of Central South University	Changsha	China	47
Zhejiang Cancer Hospital	Hangzhou	China	164